Justin Jordan, M.D., M.P.H.

Associate Professor

School: Medical School
Department: Neurology | Peter O'Donnell Jr. Brain Institute

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: McGovern Medical School at the University of Texas Health Science Center at Houston (2009)
Residency: Parkland Health & Hospital System (2013), Neurology
Fellowship: Harvard Medical School/Massachusetts General Hospital (2015), Neuro-oncology

Publications

A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations: Gonzalez Castro LN, Gavish A, Bussema L, Mount CW, Neftel C, Nomura M, Chiocca EA, Bi WL, Arnaout O, Barker FG, Brown JM, Jordan JT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR, Tirosh I, Suvà ML Genome Medicine 2025 Dec 17
Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey: Merker VL, Ma Y, Chibnik LB, Radtke HB, Kelts K, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT Orphanet Journal of Rare Diseases 2025 Dec 20
Principles for Novel Neurologic Therapeutics: An AAN Position Statement: Goldstein LB, Crowe JR, Deb A, Jordan JT, Santoro JD, Sejvar JJ, Turbes M, Shapiro RE Neurology 2025 Jun 105
Bridging the Gap Between Brain Health Guidelines and Real-world Implementation: Correa DJ, Jordan JT, Said RR CONTINUUM Lifelong Learning in Neurology 2025 Jun 31 865-884
ACR Appropriateness Criteria® Brain Tumors: Author Collaboration EP, Ivanidze J, Shih RY, Utukuri PS, Ajam AA, Auron M, Chang SM, Jordan JT, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Sheehan J, Soares BP, Soderlund KA, Wang LL, Burns J Journal of the American College of Radiology 2025 May 22 S108-S135
AAN Position: Opioids: Najib U, Cheng EM, Halker Singh RB, Ayub N, Nelson SE, Bushard PJ, Jordan JT, Sico JJ, Turbes M, Anderson WE Neurology 2025 Apr 104
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes: Lanman TA, Youssef G, Huang R, Rahman R, Desalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN Neuro-Oncology Advances 2025 Jan 7
Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas: Wood CG, Kozanno L, Stemmer-Rachamimov A, Lee DJ, Barker FG, Carter BS, Plotkin SR, Jordan JT, Chang LS, Welling DB Laryngoscope 2025
Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1”: Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rizzo JF Acta Neuropathologica 2024 Dec 148
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma: Gupta M, Bradley JD, Massaad E, Burns EJ, Georgantas NZ, Maron GE, Batten JM, Gallagher A, Thierauf J, Nayyar N, Gordon A, Jones SA, Pisapia M, Sun Y, Jones PS, Barker FG, Curry WT, Gupta R, Romero JM, Wang N, Brastianos PK, Martinez-Lage M, Tateishi K, Forst DA, Nahed BV, Batchelor TT, Ritterhouse LL, Iser F, Kessler T, Jordan JT, Dietrich J, Meyerson M, Cahill DP, Lennerz JK, Carter BS, Shankar GM Blood 2024 Sep 144 1093-1100